U.S. Markets closed

Schultz: Businesses need to do more to help people

Yahoo Finance's Julia La Roche sits down with executive chairman and former CEO of Starbucks Howard Schultz

Acer Incorporated (2353.TW)

Taiwan - Taiwan Delayed Price. Currency in TWD
Add to watchlist
15.50-0.35 (-2.21%)
At close: 1:30PM CST
Full screen
Previous Close15.85
Bid15.50 x 0
Ask15.55 x 0
Day's Range15.45 - 15.95
52 Week Range12.65 - 17.10
Avg. Volume231,300,904
Market Cap47.69B
PE Ratio (TTM)-9.00
EPS (TTM)-1.72
Earnings DateNov 8, 2017 - Nov 13, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est12.90
  • PR Newswire12 days ago

    Acer Listed on Global Sustainability Indices: 2017 DJSI and FTSE4Good

    Editor's Summary: Acer is listed on DJSI's Emerging Markets Index for the fourth consecutive year, and on the FTSE4Good Emerging Index for the second consecutive year DJSI: In addition to continuing to ...

  • Acer Showcases Its MixBot Intelligent Mixology Robot Solution
    PR Newswire18 days ago

    Acer Showcases Its MixBot Intelligent Mixology Robot Solution

    TAIPEI, Taiwan, Sept. 5, 2017 /PRNewswire/ -- Acer (TWSE: 2353, LSE: ACID) will showcase its service-oriented and intelligent mixology robot solution, the MixBot, at the 2017 Taipei International Industrial Automation Exhibition. The Acer MixBot solution, which integrates a robotic arm and an autonomous guided vehicle (AGV), will demonstrate a complete bartending solution from order-taking, drink preparation, and table service to customers, along with a business intelligence system at the backend. The MixBot shows how Acer can fully customize its robotic solutions for a variety of usage scenarios.

  • American City Business Journals2 months ago

    ​Cambridge rare disease startup Acer to go public through merger

    Acer Therapeutics, a three-year-old Cambridge biotech developing drugs for ultra-rare diseases, said Monday that it will go public through a reverse merger with a small Texas company. Acer said it would merge with Opexa Therapeutics (OPXA), which laid off all but two of its 20 employees after its lead drug for multiple sclerosis flunked a mid-stage trial in October. In connection with the deal, Acer said it would receive a $15.7 million round of financing led by TVM Capital, a life sciences venture firm based in Germany.